科華生物(002022.SZ):相關股份轉讓協議終止 珠海保聯仍是公司第一大股東
格隆匯8月5日丨科華生物(002022.SZ)公佈,2021年8月5日,公司收到公司第一大股東珠海保聯資產管理有限公司(“珠海保聯”)通知,珠海保聯與聖湘生物科技股份有限公司(“聖湘生物”)簽署了《<股份轉讓協議>之終止協議》,雙方同意自《<股份轉讓協議>之終止協議》簽署生效之日起,終止雙方於2021年5月12日簽署的《股份轉讓協議》。
主要內容如下: 1、雙方確認,《股份轉讓協議》於2021 年8 月5 日終止,雙方就前述協議的簽署、履行及終止互不承擔違約責任。2、雙方確認,珠海保聯所持有科華生物股份如重新對外轉讓,同等條件下聖湘生物具有優先購買權,且該優先權不可撤銷。 3、聖湘生物看好其與科華生物未來合作前景,加強與科華生物的戰略合作及業務協作,共同推進體外診斷“中國方案”。珠海保聯亦將努力促成聖湘生物與科華生物之間的合作,以推動中國體外診斷產業向更高層次、更高水平發展。
珠海保聯持有公司9586.3038萬股股份,仍是公司第一大股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.